Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (25)

2024

  1. Resolvin D2 prevents vascular remodeling, hypercontractility and endothelial dysfunction in obese hypertensive mice through modulation of vascular and proinflammatory factors

    Biomedicine and Pharmacotherapy, Vol. 174

2022

  1. Microsomal prostaglandin E synthase-1 is involved in the metabolic and cardiovascular alterations associated with obesity

    British Journal of Pharmacology, Vol. 179, Núm. 11, pp. 2733-2753

2019

  1. Emerging roles of lysyl oxidases in the cardiovascular system: New concepts and therapeutic challenges

    Biomolecules, Vol. 9, Núm. 10

2018

  1. MPGES-1 (Microsomal prostaglandin E synthase-1) mediates vascular dysfunction in hypertension through oxidative stress

    Hypertension, Vol. 72, Núm. 2, pp. 492-502

2016

  1. Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension

    British Journal of Pharmacology, Vol. 173, Núm. 9, pp. 1541-1555

2015

  1. Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation

    Molecular and Cellular Endocrinology, Vol. 411, pp. 20-27

  2. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension

    British Journal of Pharmacology, Vol. 172, Núm. 12, pp. 3159-3176

2014

  1. Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: Potential role in obesity

    Journal of Hypertension, Vol. 32, Núm. 5, pp. 1104-1114

  2. The potential role of leptin in the vascular remodeling associated with obesity

    International Journal of Obesity, Vol. 38, Núm. 12, pp. 1565-1572

2013

  1. Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 23, Núm. 11, pp. 1107-1114

  2. Relevance of vascular peroxisome proliferator-activated receptor γ coactivator-1α to molecular alterations in atherosclerosis

    Experimental Physiology, Vol. 98, Núm. 5, pp. 999-1008

2012

  1. A wound-like inflammatory aortic response in chronic portal hypertensive rats

    Molecular Immunology, Vol. 51, Núm. 2, pp. 177-187

2011

  1. Exposure to low mercury concentration in vivo impairs myocardial contractile function

    Toxicology and Applied Pharmacology, Vol. 255, Núm. 2, pp. 193-199

  2. Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats

    British Journal of Pharmacology, Vol. 162, Núm. 1, pp. 271-285

2009

  1. Inflammation: A link between hypertension and atherosclerosis

    Current Hypertension Reviews, Vol. 5, Núm. 1, pp. 40-48

2008

  1. Low mercury concentrations cause oxidative stress and endothelial dysfunction in conductance and resistance arteries

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 295, Núm. 3

2007

  1. Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats

    Journal of Hypertension, Vol. 25, Núm. 3, pp. 629-638

2006

  1. Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II

    JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, Vol. 7, Núm. 4, pp. 192-200

2005

  1. Eplerenone reduces oxidative stress and enhances eNOS in SHR: Vascular functional and structural consequences

    Antioxidants and Redox Signaling, Vol. 7, Núm. 9-10, pp. 1294-1301

  2. Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: Role of the NFκB/IκB system

    Journal of Hypertension, Vol. 23, Núm. 6, pp. 1167-1172